The Time for Calibrate is Now. Calibrate raises $100 Million Series B…, by Isabelle Kenyon

$ 18.50

4.7
(164)
In stock
Description

We launched Calibrate with the mission to change the way the world treats weight. In our first year, we have proven that Calibrate works. Our combination of doctor-prescribed, FDA-approved GLP-1…

Isabelle Kenyon - Agenda Contributor

Rebecca Torrence on LinkedIn: Inside the struggles at Calibrate, a new kind of weight-loss startup…

Marina Tarasova, Paloma Health, on modernizing thyroid care by The Pulse by Wharton Digital Health

Sara Reistad-Long on LinkedIn: Today Calibrate is accelerating our transformation into an…

Rebecca Torrence on LinkedIn: Inside the struggles at Calibrate, a new kind of weight-loss startup…

Kristen Coletto, Aetion, on using Real World Evidence to accelerate drug discovery and commercialization by The Pulse by Wharton Digital Health

The Time for Calibrate is Now. Calibrate raises $100 Million Series B…, by Isabelle Kenyon

Isabelle Kenyon - Calibrate

334 - Isabelle Kenyon, Founder & CEO at Calibrate

The Top 25 Consumer HealthTech Executives of 2021

Claudia Jayne (@claudiajayne) / X